Response to: Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection.

Authors :: Batista AR
Schwarze JE
Lispi M
Source :: Fertility and sterility [Fertil Steril] 2024 Feb; Vol. 121 (2), pp. 358. Date of Electronic Publication: 2023 Sep 19.
Publication Year :: 2024
Abstract: Competing Interests: Declaration of interests AR.B., J.E.S. and M.L. are employees of Merck Healthcare, Darmstadt, Germany.

Subjects :: Humans
Male
Fertilization in Vitro
Follicle Stimulating Hormone
Ovulation Induction
Recombinant Proteins
Semen
Randomized Controlled Trials as Topic
Menotropins
Sperm Injections, Intracytoplasmic

Full Text Access

Tools